NASDAQ Biotechnology Stock
Prescription
drugs are playing a greater role in healthcare and today constitute the first
line of treatment for many medical conditions. As pharmaceutical research opens
the potential for even more effective drugs, demand can be expected to increase.
For millions of people, prescription drugs equate to the hope of improved health
and quality of life. At the same ...
more
Geron is developing first-in-class biopharmaceuticals for the treatment of cancer and chronic degenerative diseases, including spinal cord injury, heart failure, diabetes and HIV/AIDS. We are advancing telomerase targeted therapies, including an anticancer drug and a cancer vaccine, through multiple clinical trials. We are also the world leader in the development ...
more
We are a biopharmaceutical company building an oncology business
by developing and commercializing innovative therapies that
target the molecular mechanisms implicated in cancer. With our
collaborators, we are developing small molecule drugs with the
goal of changing the way cancer is
treated tm .
A common feature of cancer cells is the excessive activation of ...
more
Allscripts Healthcare Solutions, Inc. is a leading provider of clinical software, connectivity and information solutions that physicians use to improve the quality of healthcare. Our businesses provide innovative
solutions that inform physicians with just right, just in time information, connect physicians to each other and to the entire community of care, and transform healthcare, improving ...
more
LUNESTA brand eszopiclone
is a non-benzodiazepine used for the treatment of insomnia. Symptoms of
insomnia include difficulty falling asleep, awakening frequently during the
night, waking up too early, an inability to fall back to sleep, or awakening
feeling unrefreshed. LUNESTA is approved for long- or short-term treatment of
sleep onset and sleep maintenance insomnia. LUNESTA is classified ...
more
We are a biopharmaceutical company focused on the development and commercialization
of drugs to treat metabolic diseases, endocrine disorders and oncology within niche markets that have unmet medical needs. Our development activities involve drugs that modulate Insulin-like Growth Factor-1 (IGF-1) activity in the human body. In the
past, we were focused on development and commercialization of ...
more
CytRx Corporation engages in the research and development of human therapeutic products. Their products are dedicated to the treatment of amyotrophic lateral sclerosis (ALS), neurodegenerative diseases, cancer, type 2 diabetes, obesity and stickle cell disease as well as other disorders.
more
We are a biopharmaceutical company focused on the discovery, development, and commercialization of small molecule drugs for the treatment of central
nervous system disorders. We currently have five programs in clinical development and several additional programs in preclinical development and discovery stages. In our most advanced proprietary program, we are entering Phase III development ...
more
We are a mid-cap biotechnology company committed to building a
scientifically strong and financially successful top tier
biopharmaceutical organization that discovers, develops and
commercializes innovative molecular targeted therapies
addressing major unmet medical needs in oncology, diabetes and
obesity.
more
We have never commercialized any of our product
candidates. We are uncertain whether any of our compounds or product candidates
will prove effective and safe in humans or meet applicable regulatory
standards. In addition, our approach to applying our expertise in multivalency
to drug discovery is unproven and may not result in the creation of
successful medicines. The risk of failure for ...
more
We are engaged in the development, manufacture, sale
and service of consumables and systems for genetic analysis in the life
sciences and clinical healthcare markets and are recognized as a market leader
in creating breakthrough tools that are advancing our understanding of the molecular
basis of life. The markets for our products currently include all aspects of
molecular biology research in ...
more
Founded in 1988, Biosite ® Incorporated is a global medical diagnostic
company utilizing a biotechnology approach to create products for the diagnosis
of critical diseases and conditions. Our primary business goal is to leverage
our research and development advances and our installed base of existing
customers to deliver first-in-class blood tests that provide diagnostic ...
more
We are
investing a significant portion of our time, personnel and financial resources
in the development of telaprevir, which is currently in Phase 2b clinical
trials. The clinical development and commercial success of telaprevir will
depend on several factors, including the following:
more
We design,
manufacture, service and market analytical and life science systems and
associated products to address the rapidly evolving needs of our customers in
life science research, pharmaceutical, biotechnology and molecular diagnostics
research, as well as in materials and chemical analysis in various industries
and government applications. Bruker BioSciences Corporation is the publicly ...
more
School
Health Industry Advisory Board, the Harvard Business School Dean’s Advisory
Board, the Advisory Board for the Kellogg Center for Executive Women, and the
University of California, San Diego Health Sciences Advisory Board. Ms. Graham
received an M.B.A. from Harvard University.
more
